Tag: PulseSelect
Medtronic announces regulatory milestones for newest cardiac mapping and ablation software
Medtronic today announced regulatory milestones for software used with two cardiac ablation platforms, including US Food and Drug Administration (FDA) clearance and a CE...
New clinical data show “excellent lesion durability” with Medtronic’s PulseSelect PFA...
Medtronic has announced the presentation of clinical study results demonstrating a high rate of durable lesion formation with the PulseSelect pulsed field ablation (PFA)...
Medtronic’s PulseSelect PFA system gains US FDA approval
Medtronic has announced that the US Food and Drug Administration (FDA) has approved the PulseSelect pulsed field ablation (PFA) system for the treatment of...